The findings are in agreement with previous observations and suggest that an immunohistochemical panel including CD43, MPO, CD117, CD68 (or CD163), CD3 and CD20 can successfully identify the majority of MS in formalin-fixed, paraffin-embedded tissue specimens [17-22]. The gene discussed is CD68; the disease is myeloid sarcoma.